Three new aromatic sulfonamide inhibitors of carbonic anhydrases I, II, IV and XII

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 28, Issue 2, 2011, Pages 289-293

  Supuran, C T ^a   Maresca, A ^a   Gregan F ^b   Remko, M ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Matej Bell University   (Spain)

^c Faculty of Natural Sciences   (Slovakia)

Author keywords

Aromatic sulfonamides; Carbonic anhydrase inhibitors; Glaucoma

Indexed keywords

4 SULFAMOYL N (3 MORPHOLINOPROPYL)BENZAMIDE; ACETAZOLAMIDE; BRINZOLAMIDE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IV; CARBONATE DEHYDRATASE XII; DORZOLAMIDE; ISOENZYME; N (3 MORPHOLINOPROPYL)BENZENE 1,4 DISULFONAMIDE; N (4 DIETHYLAMINOETHOXYBENZYL)BENZENE 1,4 BIS(SULFONAMIDE); SULFONAMIDE; UNCLASSIFIED DRUG; CARBONATE DEHYDRATASE; ISOPROTEIN;

ARTICLE; BINDING AFFINITY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SYNTHESIS; ENZYME INHIBITION; IC50; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MOLECULAR STRUCTURE; PROTEIN ISOFORMS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 84890292269     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2011.649269     Document Type: Article

References (28)

1. Maren TH. (2000). Carbonic anhydrase inhibition in ophthalmology: Aqueous humour secretion and development of sulphonamide inhibitors. In Chegwidden WR, Carter ND, Edwards YH. The Carbonic Anhydrases New Horizonts. Basel: Birkhauser Verlag. pp. 425-436.
2. Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003; 23: 146-189.
3. Supuran CT, Scozzafava A, Conway J. (2004). Carbonic anhydrase: Its inhibitors and activators. London: CRC Press.
4. Sugrue MF. New approaches to antiglaucoma therapy. J Med Chem 1997; 40: 2793-2809.
5. Sugrue MF. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Prog Retin Eye Res 2000; 19: 87-112.
6. Siesky B, Harris A, Brizendine E, Marques C, Loh J, Mackey J et al. Literature review and meta-analysis of topical carbonic anhydrase inhibitors and ocular blood flow. Surv Ophthalmol 2009; 54: 33-46.
7. Ponticello GS, Freedman MB, Habecker ChN, Lyle PA, Schwam H, Varga SL et al. Thienothiopyran-2-sulfonamides: A novel class of water-soluble carbonic anhydrase inhibitors. J Med Chem 1987; 30: 591-597.
8. Chen HH, Gross S, Liao J, McLaughlin M, Dean T, Sly WS et al. 2H-Thieno[3, 2-e]- and [2, 3-e]-1, 2-thiazine-6-sulfonamide 1, 1- dioxides as ocular hypotensive agents: Synthesis, carbonic anhydrase inhibition and evaluation in the rabbit. Bioorg Med Chem 2000; 8: 957-975.
9. Mincione F, Starnotti M, Menabuoni L, Scozzafava A, Casini A, Supuran CT. Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoylbenzenecarboxamides with strong topical antiglaucoma properties. Bioorg Med Chem Lett 2001; 11: 1787-1791.
10. Maren TH. The development of topical carbonic anhydrase inhibitors. J Glaucoma 1995; 4: 49-62.
11. Maren TH, Jankowska L, Sanyal G, Edelhauser HF. The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretion. Exp Eye Res 1983; 36: 457-479.
12. Jain A, Whitesides GM, Alexander RS, Christianson DW. Identification of two hydrophobic patches in the active-site cavity of human carbonic anhydrase II by solution-phase and solidstate studies and their use in the development of tight-binding inhibitors. J Med Chem 1994; 37: 2100-2105.
13. Remko M. Theoretical study of molecular structure and gas-phase acidity of some. Biologically active sulfonamides. J Phys Chem A 2003; 107: 720-725.
14. Remko M, von der Lieth CW. Theoretical study of gas-phase acidity, pKa, lipophilicity, and solubility of some biologically active sulfonamides. Bioorg Med Chem 2004; 12: 5395-5403.
15. Remko M. Molecular structure, pKa, lipophilicity, solubility and absorption of biologically active aromatic and heterocyclic sulfonamides. Theochem J Mol Struct 2010; 944: 34-42.
16. Remko M, Kožíšek J, Semanová J, Gregáň F. Synthesis, crystal and molecular structure of two biologically active aromatic sulfonamides and their hydrochloride salts. J Mol Struct 2010; 973: 18-26.
17. Cross PE, Gadsby B. Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 1. Substituted benzenedisulfonamides. J Med Chem 1978; 21: 845-850.
18. Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971; 246: 2561-2573.
19. Pacchiano F, Carta F, Vullo D, Scozzafava A, Supuran CT. Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides. Bioorg Med Chem Lett 2011; 21: 102-105.
20. Kolayli S, Karahalil F, Sahin H, Dincer B, Supuran CT. Characterization and inhibition studies of an α-carbonic anhydrase from the endangered sturgeon species Acipenser gueldenstaedti. J Enzyme Inhib Med Chem 2011; 26: 895-900.
21. Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions. Bioorg Med Chem Lett 2009; 19: 1855-1857.
22. Scozzafava A, Briganti F, Ilies MA, Supuran CT. Carbonic anhydrase inhibitors: Synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes. J Med Chem 2000; 43: 292-300.
23. Soltau JB, Zimmerman TJ. Changing paradigms in the medical treatment of glaucoma. Surv Ophthalmol 2002; 47: 2-5.
24. Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: Is the tail more important than the ring? J Med Chem 1999; 42: 2641-2650. Available at http: //www.acdlabs.com/products/phys-chem-lab.
25. Brechue WF. Topical carbonic anhydrase inhibitors: Physicochemical properties and aqueous humor dynamics. Rom Chem Quart Rev 1994; 2: 301-311.
26. Abbate F, Coetzee A, Casini A, Ciattini S, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride. Bioorg Med Chem Lett 2004; 14: 337-341.
27. Kim ChY, Wittington DA, Chang JS, Liao J, May JA, Christianson DW. Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV. J Med Chem 2002; 45: 888-893.
28. Vernier W, Chong W, Rewolinski D, Greasley S, Pauly T, Shaw M et al. Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: Structure-based drug design, synthesis, and biological evaluation. Bioorg Med Chem 2010; 18: 3307-3319.